奧翔藥業(603229.SH):與特定對象上海禮頤投資、上海湧鏵投資簽署終止協議
格隆匯 7 月 26日丨奧翔藥業(603229.SH)公佈,2020年4月24日,公司與上海禮頤投資管理合夥企業(有限合夥)、上海湧鏵投資管理有限公司分別簽署了《附條件生效的戰略合作協議》。
2020年7月16日,公司與上述2名戰略投資者分別簽署了《附條件生效的戰略合作協議之補充協議》。
2020年3月20日,中國證監會發布《發行監管問答——關於上市公司非公開發行股票引入戰略投資者有關事項的監管要求》,對上市公司非公開發行股票引入的戰略投資者提出一系列具體要求。經公司審慎分析並與監管部門、中介機構等反覆溝通論證,公司本次非公開發行董事會決議確定的認購對象對於本公司而言不滿足上述監管要求關於戰略投資者的相關要求。經與上述戰略投資者協商一致,2020年7月24日,公司與上述2名戰略投資者簽署了《附條件生效的戰略合作協議之終止協議》,對上述已簽署的原協議予以終止。
公司於2020年7月24日召開了第二屆董事會第十九次會議,審議通過了《關於公司與特定對象簽署戰略合作協議之終止協議的議案》,根據公司股東大會的授權,本議案無需提交股東大會審議。
2020年7月24日,公司與上海禮頤投資管理合夥企業(有限合夥)、上海湧鏵投資管理有限公司分別簽署了《終止協議》。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.